339 related articles for article (PubMed ID: 9764809)
21. Melan-A/Mart-1 expression in various melanocytic lesions and in non-melanocytic soft tissue tumours.
Orosz Z
Histopathology; 1999 Jun; 34(6):517-25. PubMed ID: 10383696
[TBL] [Abstract][Full Text] [Related]
22. Quantitative Analysis of Formaldehyde-induced Fluorescence in Paraffin-embedded Specimens of Malignant Melanomas and Other Melanocytic Lesions.
Hara H; Naito M; Harada T; Tsuboi I; Terui T; Aizawa S
Acta Derm Venereol; 2016 Mar; 96(3):309-13. PubMed ID: 26350793
[TBL] [Abstract][Full Text] [Related]
23. Immunostaining of human melanomas by a monoclonal antibody to B700 mouse melanoma antigen.
Xu X; Azumi N; Skelton HG; Hearing VJ; Gersten DM
Eur J Cancer; 1996 Jan; 32A(1):168-73. PubMed ID: 8695227
[TBL] [Abstract][Full Text] [Related]
24. Expression of melanoma-associated antigens in short-term melanoma cultures detected by RT-PCR and subsequent ELISA.
Hofbauer GF; Dummer R; Laine E; Burg G
Arch Dermatol Res; 1998 Aug; 290(8):458-61. PubMed ID: 9763311
[No Abstract] [Full Text] [Related]
25. Melan A and S100 protein immunohistochemistry in feline melanomas: 48 cases.
Ramos-Vara JA; Miller MA; Johnson GC; Turnquist SE; Kreeger JM; Watson GL
Vet Pathol; 2002 Jan; 39(1):127-32. PubMed ID: 12102204
[TBL] [Abstract][Full Text] [Related]
26. A103 immunostaining in the diagnosis of adrenal cortical tumors: an immunohistochemical study of 316 cases.
Loy TS; Phillips RW; Linder CL
Arch Pathol Lab Med; 2002 Feb; 126(2):170-2. PubMed ID: 11825112
[TBL] [Abstract][Full Text] [Related]
27. Towards quantitative mRNA analysis in paraffin-embedded tissues using real-time reverse transcriptase-polymerase chain reaction: a methodological study on lymph nodes from melanoma patients.
Abrahamsen HN; Steiniche T; Nexo E; Hamilton-Dutoit SJ; Sorensen BS
J Mol Diagn; 2003 Feb; 5(1):34-41. PubMed ID: 12552078
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of MART-1, tyrosinase, and SM5-1 in primary and metastatic melanoma.
Reinke S; Königer P; Herberth G; Audring H; Wang H; Ma J; Guo Y; Sterry W; Trefzer U
Am J Dermatopathol; 2005 Oct; 27(5):401-6. PubMed ID: 16148409
[TBL] [Abstract][Full Text] [Related]
29. Culture of melanoma cells in 3-dimensional architectures results in impaired immunorecognition by cytotoxic T lymphocytes specific for Melan-A/MART-1 tumor-associated antigen.
Ghosh S; Rosenthal R; Zajac P; Weber WP; Oertli D; Heberer M; Martin I; Spagnoli GC; Reschner A
Ann Surg; 2005 Dec; 242(6):851-7, discussion 858. PubMed ID: 16327495
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours.
Jungbluth AA; Stockert E; Chen YT; Kolb D; Iversen K; Coplan K; Williamson B; Altorki N; Busam KJ; Old LJ
Br J Cancer; 2000 Aug; 83(4):493-7. PubMed ID: 10945497
[TBL] [Abstract][Full Text] [Related]
31. Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants.
Blessing K; Sanders DS; Grant JJ
Histopathology; 1998 Feb; 32(2):139-46. PubMed ID: 9543670
[TBL] [Abstract][Full Text] [Related]
32. A comparative immunohistochemical study of MART-1 expression in Spitz nevi, ordinary melanocytic nevi, and malignant melanomas.
Bergman R; Azzam H; Sprecher E; Manov L; Munichor M; Friedman-Birnbaum R; Ben-Itzhak O
J Am Acad Dermatol; 2000 Mar; 42(3):496-500. PubMed ID: 10688724
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.
Böni R; Burg G; Doguoglu A; Ilg EC; Schäfer BW; Müller B; Heizmann CW
Br J Dermatol; 1997 Jul; 137(1):39-43. PubMed ID: 9274623
[TBL] [Abstract][Full Text] [Related]
34. Melanoma-associated antigen recognized by T cells (MART-1): the advent of a preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspiration.
Fetsch PA; Marincola FM; Filie A; Hijazi YM; Kleiner DE; Abati A
Cancer; 1999 Feb; 87(1):37-42. PubMed ID: 10096358
[TBL] [Abstract][Full Text] [Related]
35. Serological analysis of Melan-A(MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas.
Chen YT; Stockert E; Jungbluth A; Tsang S; Coplan KA; Scanlan MJ; Old LJ
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5915-9. PubMed ID: 8650193
[TBL] [Abstract][Full Text] [Related]
36. L1 adhesion molecule (CD 171) in development and progression of human malignant melanoma.
Fogel M; Mechtersheimer S; Huszar M; Smirnov A; Abu-Dahi A; Tilgen W; Reichrath J; Georg T; Altevogt P; Gutwein P
Cancer Lett; 2003 Jan; 189(2):237-47. PubMed ID: 12490317
[TBL] [Abstract][Full Text] [Related]
37. Expression of melanocyte-associated markers gp-100 and Melan-A/MART-1 in angiomyolipomas. An immunohistochemical and rt-PCR analysis.
Jungbluth AA; Iversen K; Coplan K; Williamson B; Chen YT; Stockert E; Old LJ; Busam KJ
Virchows Arch; 1999 May; 434(5):429-35. PubMed ID: 10389626
[TBL] [Abstract][Full Text] [Related]
38. [Reactivity of five different antibodies with benign and malignant melanocytic lesions].
Plótár V; Szentirmay Z; Orosz Z
Magy Onkol; 2008 Dec; 52(4):363-73. PubMed ID: 19068464
[TBL] [Abstract][Full Text] [Related]
39. HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma.
Zubovits J; Buzney E; Yu L; Duncan LM
Hum Pathol; 2004 Feb; 35(2):217-23. PubMed ID: 14991540
[TBL] [Abstract][Full Text] [Related]
40. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
